investigated the role of NO in the development of tolerance to prolonged administration of alpha-2 adrenergic agonists. Method: Tolerance was assessed by the attenuation of the inhibitory effect of dexmedetomidine (DEX), a highly specific alpha-2 adrenergic agonist, on prostaglandin E-1 (PGE-I) stimulated adenylyl cyclase (AC) in the mouse neuroblastoma X rat glioma hybrid cell (NG108-15) line (neuronal cells which express the alpha-2 8 adrenergic receptor). Cells were chronically exposed to 0.1 pM DEX for 2, 4, 8, 14 hours and DEX + 100 pM N-nitro-L-arginine, a NO synthase (NOS) inhibitor, for 2 hours. The cells were also exposed to L-arginine (a NO donor) for 20 minutes. The cells were then washed three times and acutely exposed to varying doses of DEX (IpM to I pM) and the AC activity measured. Results: Cells exposed to DEX for 2 hours or longer were desensitized as evidenced by a 10 fold shift to the right of the DEX dose response curve. The cells exposed to DEX and N-nitro-Larginine for 2 hours showed no such desensitization. Cells exposed to L-arginine (without DEX) demonstrated a 6 fold shift to the right in the DEX dose response curve. Summary: Tolerance to DEX can be induced in an in-vitro model. This is demonstrated by the right shift in the dose response curve, after 2 hours exposure to DEX. This effect can be reproduced by NO exposure after only 20 minutes, and prevented when NOS is inhibited during prolonged DEX exposure. 
is present in atherosclerotic lesions, binds to lipoproteins and activates complement, but direct vascular effects of CRP have not been reported. Methods: Endothelium-intact aortic rings from male SpragueDawley rats were incubated for 4 h in serum free Dulbecco's modified Eagle's medium containing isolated pure human CRP (200 mg/l), or its buffer, and then mounted in organ baths. Concentrationresponse curves to phenylephrine (PE) (10 '-IO.'M) and acetylcholine (Ach) (lOp-lOJM) were constructed. The effects of endothelial denudation, actinomycin D (IO'M; to inhibit protein synthesis), L-NAME (3xIO.M. to inhibit NO synthesis), 1400W (IO'M, to selectivcly inhibit iNOS) or methoxyacetylserotonin (10'M to inhibit tetrahydrobiopterin synthesis) were also determined. Stock CRP solution and its solvent buffer contained <0.5 n g / d bacterial lipopolysaccharide (LPS) by timulus chromogenic assay. To exclude LPS effects and confirm the specific role of CRP, the stock CRP preparation was absorbed before use with Sepharosephosphoethanolamine beads, reducing the final CRP concentration to 0.005 rng/l. Changes in protein levels of eNOS and GTPcyclohydrolase-1 (the rate limiting enzyme for tetrahydrobiopterin synthesis) were estimated by SDS-PAGE and Westem blotting. Results: Human CRP produced marked hyporeactivity to PE (P<O.O001, 2-way ANOVA) in rat aorta and enhanced relaxation to Ach (P<O.OOOI). This effect was abolished by specific removal of CRP, by endothelial denudation, by pretreatment with actinomycin D, and treatment with L-NAME or methoxyacetylserotonin, but not by 1400W. Westem blots showed an increase in GTPcyclohydrolase-1 levels. Conclusion: Human CRP causes hyporeactivity to PE in isolated rat aorta by increasing NO synthesis from eNOS, through a pathway that may involve induction of the eNOS co-factor tetrahydrobiopterin. The pathophysiological significance of these findings is currently being studied. The acute coronary syndromes encompass a spectrum of disorders that present with chest discomfort caused by myocardial ischaemia. Platelet and endothelial activation secondary to plaque instability have been implicated as major pathogenic mechanisms in the acute coronary syndromes. Thrombospondin (TSP) is a matrix glycoprotein released from the a-granules of platelets and activated endothelial cells. The aim of this investigation therefore was to examine circulating plasma levels of TSP and the cellular adhesion molecules E-selectin and intra-cellular adhesion molecule in patients with acute coronary syndromes. Thirty four patients with ACS and 24 patients with non-cardiac chest pain were studied. TSP was measured by in-house radioimmunoassay whilst ELAM and ICAM were measured by ELlSA methodology. The integrins aIIbp3 and avo3 play important roles in thrombosis (alIbp3). cell proliferation and migration (avp3). processes thought to be involved in restenosis following coronary intervention. We assessed the effect of a selective alIbp3 antagonist (Lamifiban), a selective avp3 antagonist (V0514) and a combined alIbp3/avp3 antagonist ((33580) upon porcine vascular smooth muscle cell (VSMC) adhesion and the response to balloon injury in a porcine model.
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Methods:
The effect of each antagonist on VSMC adhesion to vitronectin, fibronectin, laminin and collagen type IV coated wells was assessed using standard methods. For in vivo experiments, 37
